EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

LOGO

 

 

Press Release

Financial and Investor Contact:

John R. Potapchuk

631-501-7035

john.potapchuk@gentiva.com

Media Contact:

David Fluhrer

631-501-7102, 516-589-0778

david.fluhrer@gentiva.com

FOR IMMEDIATE RELEASE

Gentiva® Health Services Announces First Quarter 2008 Results

and Reaffirms Financial Outlook

Melville, NY, May 1, 2008 — Gentiva Health Services, Inc. (NASDAQ: GTIV), the nation's leading provider of comprehensive home health services, today reported the following financial results for the first quarter ended March 30, 2008:

 

   

Net revenues increased 8% to $323.7 million versus the first quarter ended April 1, 2007.

 

   

Net income increased 13% to $7.7 million, or $0.27 per diluted share, versus $6.8 million, or $0.24 per diluted share, for the prior year period. Average diluted shares were 29.0 million versus 28.4 million in the 2007 first quarter.

 

   

Earnings before interest, taxes, depreciation and amortization (EBITDA) increased 3% to $23.8 million in the first quarter of 2008. EBITDA as a percentage of net revenues was 7.4% in the 2008 first quarter versus 7.7% in the prior year period.

 

   

EBITDA included restructuring and integration costs of $0.3 million for the first quarter of 2008 as compared to $1.0 million for the prior year period.

“Gentiva’s first quarter was an important transitional period as we adapted to new Medicare Prospective Payment System (PPS) rules, integrated our recent Mississippi acquisition and implemented contract renewals within CareCentrix,” said Gentiva Chairman and CEO Ron Malone. “While we were pleased with our revenue growth, some of the quarter’s events had a short-term, moderating effect on profitability. However, we are able to reaffirm our financial outlook for the full year, based on our review of current business trends, our progress in adapting to the changed Medicare environment, and our commercial business opportunities. We expect 2008 to be another good year for Gentiva.”

 

3 Huntington Quadrangle, Suite 200S, Melville, NY 11747-4627


The Company noted the following first quarter performance highlights in its Home Health segment:

 

   

Home Health revenues were up 6% to $217.0 million versus the prior year period, driven primarily by continuing growth from the Company’s expanding specialty programs, an increase in revenues from the segment’s commercial business as a result of the Company’s ongoing pricing strategy, and the inclusion of about $3 million in net revenues from Home Health Care Affiliates, Inc., in Mississippi, which was acquired by Gentiva on February 29, 2008.

 

   

Home Health operating contribution rose 4% to $31.2 million, with the operating contribution margin at 14.4% in the first quarter of 2008 versus 14.6% in the prior year period. While the segment’s operating contribution has continued to benefit from the change in revenue mix to higher-margin payers, results were affected by costs related primarily to Gentiva’s adoption of new PPS rules and recruitment initiatives to grow capacity and productivity.

 

   

Revenues for Gentiva’s Medicare PPS home health business increased more than 7% versus the prior year period. Patient admissions remained strong, although the current impact of new PPS rules contributed to a revenue growth rate below those of recent quarters. Medicare Advantage revenues in Home Health — under which Gentiva is paid for patient episodes similar to the rate structure and levels of Medicare PPS — more than doubled during the first quarter versus the prior year period. As a result, growth in episodic revenues (the combined revenues from Medicare PPS and Medicare Advantage business paid on an episodic basis) was 11% year-over-year, despite the adverse impact of PPS changes.

Gentiva reported the following results in its CareCentrix and Other Related Services segments:

 

   

Revenues for CareCentrix rose more than 18% to $77.8 million as this segment continued to benefit from its servicing of increased managed care membership enrollments and new business.

 

   

CareCentrix’ operating contribution declined by 9% to $6.3 million due primarily to expected short-term increases in utilization under capitated agreements, selected pricing changes resulting from a recent contract extension with CIGNA HealthCare, and investments in CareCentrix’ expanded sales force. The Company anticipates additional business opportunities for CareCentrix during the remainder of 2008, including the continuing shift of CIGNA’s membership from capitated to fee-for-service plans, and potential benefits from CIGNA’s first quarter acquisition of Great-West Healthcare.

 

   

Net revenues and operating contribution for the smaller Other Related Services segment, which consists of hospice, respiratory and home medical equipment, infusion therapy and consulting, were slightly below the prior year period as the Company continued to make investments and operational changes aimed at improving the segment’s financial performance.

 

2


During the first quarter of 2008, Gentiva used $43 million of cash and incurred an additional $12 million in debt to fund the Home Health Care Affiliates acquisition. Despite the resulting increase in long-term debt to $322 million at March 30, 2008, Gentiva’s leverage ratio remains below 3.0 and this has allowed the Company to maintain lower interest margins on its revolving credit and term loan borrowings as compared to the prior year.

Gentiva also reaffirmed its 2008 financial outlook of net revenues in a range of $1.28 billion to $1.32 billion and diluted earnings per share in a range between $1.32 and $1.40.

Non-GAAP Financial Measures

The information provided in this press release includes certain non-GAAP financial measures as defined under Securities and Exchange Commission (SEC) rules. In accordance with SEC rules, the Company has provided, in the supplemental information and the footnotes to the tables, a reconciliation of those measures to the most directly comparable GAAP measures.

Conference Call and Web Cast Details

The Company will comment further on its first quarter results during its conference call and live web cast to be held Thursday, May 1, 2008, at 10:00 a.m. Eastern Time. To participate in the call from the United States, Canada or an international location, dial (973) 935-2408 and reference call #42736083. The web cast is an audio-only, one-way event. Web cast listeners who wish to ask questions must participate in the conference call. Log onto http://investors.gentiva.com/events.cfm to hear the web cast. This press release is accessible at http://investors.gentiva.com/releases.cfm and a transcript of the conference call is expected to be available on the site within 36 hours after the call.

About Gentiva Health Services, Inc.

Gentiva Health Services, Inc. is the nation's leading provider of comprehensive home health services. The Company serves patients across the United States, through its direct service delivery units or through CareCentrix®, which manages home health services for major managed care organizations. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; respiratory therapy and home medical equipment; infusion therapy services; and other therapies and services. Gentiva's revenues are generated from federal and state government programs, commercial insurance and individual consumers. For more information, visit Gentiva's web site, http://www.gentiva.com, and its investor relations section at http://investors.gentiva.com. GTIV-E

(tables and notes follow)

 

3


(in 000's, except per share data)    1st Quarter  
     2008     2007  
Statements of Income     

Net revenues

   $ 323,722     $ 299,542  

Cost of services and goods sold

     187,199       170,121  
                

Gross profit

     136,523       129,421  

Selling, general and administrative expenses

     117,880       111,065  
                

Operating income

     18,643       18,356  

Interest expense

     (6,093 )     (7,139 )

Interest income

     667       817  
                

Income before income taxes

     13,217       12,034  

Income tax expense

     5,494       5,195  
                

Net income

   $ 7,723     $ 6,839  
                

Earnings per Share

    

Net income:

    

Basic

   $ 0.27     $ 0.25  
                

Diluted

   $ 0.27     $ 0.24  
                

Average shares outstanding:

    

Basic

     28,282       27,530  
                

Diluted

     29,043       28,439  
                
    
     Mar 30, 2008     Dec 30, 2007  
Condensed Balance Sheets     

ASSETS

    

Cash, cash equivalents and restricted cash (A)

   $ 16,382     $ 36,181  

Short-term investments (B)

     1,350       31,250  

Accounts receivable, net (C)

     230,190       207,801  

Deferred tax assets

     17,551       18,859  

Prepaid expenses and other current assets

     16,041       14,415  
                

Total current assets

     281,514       308,506  

Long-term investments (B)

     12,641       —    

Fixed assets, net

     62,534       59,562  

Intangible assets, net

     233,872       211,602  

Goodwill

     310,909       276,100  

Other assets

     25,893       26,463  
                

Total assets

   $ 927,363     $ 882,233  
                

LIABILITIES AND SHAREHOLDERS’ EQUITY

    

Current portion of long-term debt

   $ 3,072     $ 2,304  

Accounts payable

     24,219       20,093  

Payroll and related taxes

     28,057       17,163  

Deferred revenue

     31,790       29,015  

Medicare liabilities

     8,257       7,985  

Cost of claims incurred but not reported

     22,732       24,321  

Obligations under insurance programs

     36,733       36,816  

Other accrued expenses

     39,616       42,282  
                

Total current liabilities

     194,476       179,979  

Long-term debt

     318,928       307,696  

Deferred tax liabilities, net

     55,218       48,572  

Other liabilities

     21,672       22,557  

Shareholders' equity

     337,069       323,429  
                

Total liabilities and shareholders’ equity

   $ 927,363     $ 882,233  
                

Common shares outstanding

     28,402       28,046  
                

 

(A) Cash, cash equivalents and restricted cash included restricted cash of $0.3 million at March 30, 2008 and $22.0 million at December 30, 2007.
(B) Short-term and long-term investments at March 30, 2008 and December 30, 2007 consisted of AAA-rated auction rate securities. At March 30, 2008, long-term investments were presented net of a $0.4 million valuation allowance, the charge for which was recorded in Shareholders’ Equity.
(C) Accounts receivable, net, included an allowance for doubtful accounts of $9.3 million and $9.4 million at March 30, 2008 and December 30, 2007, respectively.

 

4


(in 000's)    1st Quarter  
     2008     2007  
Condensed Statements of Cash Flows     

OPERATING ACTIVITIES:

    

Net income

   $ 7,723     $ 6,839  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

     5,151       4,783  

Amortization of debt issuance costs

     287       206  

Provision for doubtful accounts

     2,600       1,992  

Equity-based compensation expense

     1,734       1,652  

Windfall tax benefits associated with equity-based compensation

     (1,235 )     (241 )

Deferred income taxes

     4,848       3,699  

Changes in assets and liabilities, net of acquired business:

    

Accounts receivable

     (19,598 )     (17,741 )

Prepaid expenses and other current assets

     (2,151 )     (4,863 )

Current liabilities

     8,825       18,660  

Other, net

     (49 )     695  
                

Net cash provided by operating activities

     8,135       15,681  
                

INVESTING ACTIVITIES:

    

Purchase of fixed assets

     (6,624 )     (6,445 )

Acquisition of businesses, net of cash acquired

     (47,405 )     —    

Purchases of short-term investments available-for-sale

     (28,000 )     (17,000 )

Maturities of short-term investments available-for-sale

     44,900       12,800  
                

Net cash used in investing activities

     (37,129 )     (10,645 )
                

FINANCING ACTIVITIES:

    

Proceeds from issuance of common stock

     4,119       2,188  

Windfall tax benefits associated with equity-based compensation

     1,235       241  

Borrowings under revolving credit facility

     12,000       —    

Home Health Care Affiliates debt repayments

     (7,420 )     —    

Debt issuance costs

     (432 )     —    

Other debt repayments

     —         (7,000 )

Repayment of capital lease obligations

     (307 )     (294 )
                

Net cash provided by (used in) financing activities

     9,195       (4,865 )
                

Net change in cash, cash equivalents and restricted cash

     (19,799 )     171  

Cash, cash equivalents and restricted cash at beginning of period

     36,181       32,910  
                

Cash, cash equivalents and restricted cash at end of period

   $ 16,382     $ 33,081  
                

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:

    

Interest paid

   $ 5,702     $ 7,912  

Income taxes paid, net of refunds

   $ 416     $ 286  

 

5


(in 000's)    1st Quarter  
     2008     2007  

Supplemental Information

    

Segment Information (1)

    

Net revenues

    

Home Health

   $ 217,000     $ 205,031  

CareCentrix

     77,848       65,890  

Other Related Services

     29,818       30,563  

Intersegment revenues

     (944 )     (1,942 )
                

Total net revenues

   $ 323,722     $ 299,542  
                

Operating contribution (3)

    

Home Health

   $ 31,202     $ 29,988  

CareCentrix

     6,326       6,954  

Other Related Services

     2,845       3,987  
                

Total operating contribution

     40,373       40,929  

Corporate expenses

     (16,579 )     (17,790 )

Depreciation and amortization

     (5,151 )     (4,783 )

Interest expense, net

     (5,426 )     (6,322 )
                

Income before income taxes

   $ 13,217     $ 12,034  
                
     1st Quarter  
     2008     2007  

Net Revenues by Major Payer Source:

    

Medicare

    

Home Health

   $ 145,106     $ 135,254  

Other

     14,574       15,289  
                

Total Medicare

     159,680       150,543  

Medicaid and local government

     35,365       38,327  

Commercial insurance and other (4)

     128,677       110,672  
                

Total net revenues

   $ 323,722     $ 299,542  
                
A reconciliation of EBITDA to Net income - As Reported amounts follows: (2)     
     1st Quarter  
     2008     2007  

EBITDA (3)

   $ 23,794     $ 23,139  

Depreciation and amortization

     (5,151 )     (4,783 )

Interest expense, net

     (5,426 )     (6,322 )
                

Income before income taxes

     13,217       12,034  

Income tax expense (5)

     (5,494 )     (5,195 )
                

Net income - As Reported

   $ 7,723     $ 6,839  
                

 

6


 

Notes:

 

1) The Company’s senior management evaluates performance and allocates resources based on operating contributions of the reportable segments, which exclude corporate expenses, depreciation, amortization, and interest expense (net), but include revenues and all other costs directly attributable to the specific segment.
2) EBITDA, a non-GAAP financial measure, is defined as income before interest expense (net of interest income), income taxes, depreciation and amortization. Management uses EBITDA to evaluate overall performance and compare current operating results with other companies in the healthcare industry. EBITDA should not be considered in isolation or as a substitute for net income, operating income or cash flow statement data determined in accordance with accounting principles generally accepted in the United States. Because EBITDA is not a measure of financial performance under accounting principles generally accepted in the United States and is susceptible to varying calculations, it may not be comparable to similarly titled measures in other companies.
3) Operating contribution and EBITDA for the first quarter of 2008 included restructuring and integration costs of $0.3 million, of which $0.1 million is associated with the Home Health segment, and $0.2 million is included in corporate expenses. For the first quarter of 2007, operating contribution and EBITDA included $0.3 million associated with the Home Health segment and $0.7 million associated with corporate expenses.
4) Commercial insurance and other revenues included revenues from Medicare Advantage business paid on an episodic basis of $11.1 million for the first quarter of 2008 and $5.4 million for the first quarter of 2007.
5) The Company’s effective tax rate was 41.6% and 43.2% for the first quarters of 2008 and 2007, respectively.

Forward-Looking Statement

Certain statements contained in this news release, including, without limitation, statements containing the words “believes,” “anticipates,” “intends,” “expects,” “assumes,” “trends” and similar expressions, constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company’s current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These factors include, among others, the following: economic and business conditions; demographic changes; changes in, or failure to comply with, existing governmental regulations; legislative proposals for healthcare reform; changes in Medicare and Medicaid reimbursement levels, including changes to the Medicare home health Prospective Payment System effective January 1, 2008; effects of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to natural disasters or terrorist acts; ability to successfully integrate the operations of acquisitions the Company may make and achieve expected synergies and operational efficiencies within expected time-frames; effect on liquidity of the Company’s debt service requirements; a material shift in utilization within capitated agreements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended December 30, 2007.

# # #

 

7